Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (205)	5/7/1998 2:42:00 AM
From: scaram(o)uche	Respond to of 3044

Richard: Sorry the link didn't work. I tested it and everything. Oh well, it really was just fluff. Regarding EntreMed...... do you need anyone to mow the lawns, carry your clubs, or wash the car?? Congrats! Rick

To: Richard Haugland who wrote (205)	5/10/1998 12:03:00 PM
From: Richard Haugland	Read Replies (1) \| Respond to of 3044

MLNM downgrades. Analysts now show 6 "strong buy" and 2 "buy" versus a perfect "strong buy" rating two months ago. biz.yahoo.com Some upward revision of earnings estimates for the current quarter (less loss) and downward for the subsequent quarter. Seems more like a response to the stock's price drop than a prediction of reality. MLNM handily beat the analysts' number last quarter. I also noted that Sangstat, which also used to have a perfect "strong buy" recommendation in Zacks now has some (or one) simple "buy" recommendation. I had hoped that the Entremed enthusiasm of this past week would invigorate development-stage pharma companies but I have not seen much positive effect.